SCHEMBL1147571

SCHEMBL1147571

Clc1ccc2c(Sc3ccnc4cc(Cl)ccc34)ccnc2c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRNP P04156 2/20 0.60
RXFP1 Q9HBX9 2/20 0.60
KDM4E B2RXH2 1/20 0.60
NR4A2 P43354 3/20 0.59
SOS2 Q07890 1/20 0.59
KMT2A Q03164 3/20 0.55
POLB P06746 1/20 0.55
CYP1A2 P05177 1/20 0.53
MAPT P10636 3/20 0.50
TDP1 Q9NUW8 2/20 0.50
CCR1 P32246 1/20 0.50
PKM P14618 1/20 0.50
ALOX15 P16050 1/20 0.50
CASP1 P29466 1/20 0.50
HSD17B10 Q99714 1/20 0.50
CHKA P35790 2/20 0.49
FERMT2 Q96AC1 2/20 0.47
MEN1 O00255 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
KMT5B Q4FZB7 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15452534 0.88 PRNP (0.57) PRNPRXFP1KDM4ENR4A2SOS2
SCHEMBL27303567 0.85 PRNP (0.51) PRNPRXFP1KDM4ENR4A2SOS2
SCHEMBL27295461 0.84 NR4A2 (0.51) PRNPRXFP1KDM4ENR4A2SOS2
SCHEMBL8544136 0.83 PRNP (0.52) PRNPRXFP1KDM4ENR4A2SOS2
SCHEMBL12657025 0.81 PRNP (0.47) PRNPRXFP1KDM4ENR4A2SOS2
SCHEMBL9397349 0.81 PRNP (0.55) PRNPRXFP1KDM4ENR4A2SOS2
SCHEMBL8539034 0.81 PRNP (0.53) PRNPRXFP1KDM4ENR4A2SOS2
SCHEMBL5401241 0.80 NR4A2 (0.50) PRNPRXFP1KDM4ENR4A2SOS2
SCHEMBL8541256 0.80 PRNP (0.54) PRNPRXFP1KDM4ENR4A2SOS2
SCHEMBL2121573 0.80 PRNP (0.46) PRNPRXFP1KDM4ENR4A2SOS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110045100-A1 Antimalarial Quinolines and Methods of Use Thereof GEORGETOWN UNIVERSITY (US) 2011-02-24 US disclosed
WO-2009148659-A2 ANTIMALARIAL QUINOLINES AND METHODS OF USE THEREOF GEORGETOWN UNIVERSITY (US) 2009-12-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110045100-A1 Antimalarial Quinolines and Methods of Use Thereof NQO2, QTRT1, QTRT2 PRNP 2589/4885RXFP1 3727/4885KDM4E 1366/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.